Influx Healthtech Limited

Company Profile
Company Name Influx Healthtech Limited
Open Date 18-06-2025
Close Date 20-06-2025
Exchange NSE SME
Lot Size 1,200 Shares
Issue Price ₹91-₹96
Issue Size 61,00,800 shares
Application Amount ₹1,15,200
Recommendation Apply
The company was incorporated on September 28th 2020, in Mumbai. The registered office is Kandivali West, Mumbai. The company has been in the business of the contract manufacturing of Dietary/Nutritional supplements, Cosmetics, Herbal Formulations, Homecare and Veterinary supplements. The majority of the revenue for the company, comes from the Nutraceuticals division which accounts for 90% of their revenue. The company has 179 permanent employees as of the FY2024-2025.
(Read more on the review)

Financial Summary in Lakhs

KPIs Mar-23 Mar-24 Mar-25
Revenue 7,605.65 9,996.51 10,485.30
EBITDA 973.63 1,493.28 1,787.90
Net Profit 719.63 1,112.80 1,336.59
RoCE 73.85% 56.57% 41.39%
ROE 61.76% 48.85% 36.98%
P/E 24.24 15.66 13.04

Tentative Timeline

Opening Date 18-06-2025
Closing Date 20-06-2025
Basis of Allotment 23-06-2025
Initiation of Refunds 24-06-2025
Credit of Shares to Demat 24-06-2025
Listing Date 25-06-2025

Objects of the Issue

Funding of capital expenditure towards a new manufacturing facility for the veterinary supplements division - 1,158.58 Lakhs
Funding of capital expenditure towards setup of a new manufacturing facility for the nutraceuticals division - 2,260.11 Lakhs
Purchase of machineries for cosmetics and homecare division - 275.65 Lakhs
General corporate purposes

Contact Information

Registered Office Influx Healhttech Limited 109, Ghanshyam Enclave Premises Co-op Soc Plot No. 856, Laljipada Kandivali West, Mumbai, Maharashtra, 400067
Phone +91 7045997809
Email cs@influxhealthtech.com
Website https://influxhealthtech.com/

Registrar Details

Name Maashitla Securities Private Limited
Phone +91-11-45121795-96
Email investor.ipo@maashitla.com
Website https://maashitla.com/allotment-status/public-issues

IPO Reservation

NII (HNI) Shares Offered Not less than 15% of the Net Issue
Retail Shares Offered Not less than 35% of the Net Issue
Qualified Institutional Buyers Not more than 50% of the Net Issue

Shareholding Pattern

Share Holding Pre Issue (Promoters) 99.85%
Share Holding Post Issue (Promoters) 73.53%

Contact Us to Enable Your Success!